Institutional investors purchased a net $670.6 thousand shares of GHDX during the quarter ended March 2017 and now own 91.72% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
COLUMBIA WANGER ASSET MANAGEMENT... Bought 332.3 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 278.4 Thousand shares of Genomic Health Inc
RENAISSANCE TECHNOLOGIES LLC Bought 156.5 Thousand shares of Genomic Health Inc